Objective
The proposed Strep evaluates the potential of PlGF as a pharmaceutical for major chronic progressive cardiac disorders (ischemic heart disease, heart failure and arterial insufficiency (intermittent claudication and critical limb ischemia)) and as a biomarker for cardiovascular disease. The proposed Strep is based on: 1) basic research on the VEGF-signaling pathway (via PlGF) performed over the last five years (CTG, VIB-3); 2) prototype research performed with recombinant PlGF for pro-angiogenesis (GT and TG); and 3) basic research on the association of plasma PlGF and VEGF levels and human diseases (IGB) and 4) the development of a diagnostic test to evaluate PlGF as a biomarker for cardiovascular disease. The comprehensive strategy encompasses the validation of the "proof of concept" observations made by the academic parties of the consortium into therapeutic concepts in new relevant small animal models, development of industrial scale GLP/GMP quality materials and confirmation of their safety and efficacy in new, relevant large animal models. The strategy will be applied to the development of pro-angiogenic recombinant PlGF in ischemic heart disease models and in peripheral arterial insufficiency models. In parallel the value of PlGF as a predictive biomarker and as a diagnostic test for cardiovascular disease will be explored in a collaborative effort with a large diagnostic company. The principal aim of the project is to develop a new, safe and efficacious medicine to enhance the formation of blood vessels and in doing so, to develop new treatment paradigms for heart failure and limb ischemia.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine pharmacology and pharmacy drug discovery
- medical and health sciences clinical medicine cardiology cardiovascular diseases arteriosclerosis
- medical and health sciences clinical medicine endocrinology diabetes
- medical and health sciences basic medicine toxicology
- medical and health sciences health sciences nutrition obesity
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP6-2005-LIFESCIHEALTH-7
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
HEVERLEE
Belgium
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.